Advertisement Millennium launches Surgex - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Millennium launches Surgex

Millennium Biotechnologies, a wholly owned subsidiary of Millennium Biotechnologies Group, has launched Surgex, a sports nutritional product that is intended to meet growing demand among elite-level professional and amateur athletes for nutritional support.

According to the company, Surgex constitutes a blend of extended release proteins, anti-oxidants, amino acids and whole food calories to meet the multi-nutritional needs of strength, speed, and endurance athletes. It works to counteract the stress that exercise puts on the body through an all-in-one nutritional supplement.

In double-blind placebo-controlled trials at the Rutgers University Human Performance Lab, Surgex significantly outperformed leading competitive products by assisting in reducing the damaging effects of exercise by improving peak power outputs, lowering oxidative stress and inflammatory markers, reducing fatigue (poor energy recovery) and the breakdown of muscle (post exercise wasting), as well as the lessening of free radical production (oxidative stress). The formula meets NCAA guidelines for use by collegiate athletes and is certified to contain no banned substances.

Mark Mirken, chief operating officer of Millennium Biotechnologies, said: “This is clearly a multi-billion dollar industry worldwide and to leverage our proven, patent protected formulas, in global sports market place will significantly enhance share holder value.”